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Which conditions treated by neurosurgeons cause the worst economic hardship in
low middle-income in countries? How can public health financing be responsive to
the inequities in the delivery of neurosurgical care? This review article frames the
objectives of equity, quality, and efficiency in health financing to the goals of global
neurosurgery. In order to glean provider perspectives on the affordability of neurosurgical
care in low-resource settings, we did a survey of neurosurgeons from Indonesia and the
Philippines and identified that the care of socioeconomically disadvantaged patients with
malignant intracranial tumors were found to incur the highest out-of-pocket expenses.
Additionally, the surveyed neurosurgeons also observed that treatment of traumatic brain
injury may have to require greater financial subsidies. It is therefore imperative to frame
health financing alongside the goals of equity, efficiency, and quality of neurosurgical care
for the impoverished. Using principles and perspectives from managerial economics and
public health, we conceptualize an implementation framework that addresses both the
supply and demand sides of healthcare provision as applied to neurosurgery. For the
supply side, strategic purchasing enables a systematic and contractual management
of payment arrangements that provide performance-based economic incentives for
providers. For the demand side, conditional cash transfers similarly leverages on financial
incentives on the part of patients to reward certain health-seeking behaviors that
significantly influence clinical outcomes. These health financing strategies are formulated
in order to ultimately build neurosurgical capacity in LMICs, improve access to care for
patients, and ensure financial risk protection.
Keywords: health financing, global neurosurgery, social health insurance, strategic purchasing, conditional cash
transfer (CCT), out-of-pocket (OOP) expenses
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INTRODUCTION

Existing frameworks from these disciplines permit exploration
of financial risks that burden the patients that can potentially
be averted by the roles of various agents in the surgical
and health systems. We propose a conceptual framework for
implementation to inform future policymaking related to the
financing of public neurosurgical services in Indonesia and
the Philippines.

The costs accompanying the provision of neurosurgical care in
low middle-income countries (LMICs) constitute as barriers to
access among the socioeconomically disadvantaged (1). For the
often life-threatening neurosurgical conditions, financial barriers
that need to be overcome frequently cause economic hardships
to the household in which a patient belongs to. Families with
a patient needing neurosurgical care are at risk for financial
catastrophe and impoverishment, and this is especially true in
LMICs (2, 3). The increasing costs of healthcare—including
neurosurgery—also further burdens the existing health financing
mechanisms in the health systems of LMICs. Particularly in
low-resource settings of public hospitals where the poorer
segments of the population are served, financial risk protection
becomes an important consideration (4, 5). The elimination
of catastrophic and impoverishing expenditures remains an
important goal for health systems to improve the accessibility
of neurosurgery. In this article, we explore the most financially
catastrophic neurosurgical disorders that are encountered in
public neurosurgical centers in Indonesia and the Philippines.
We also describe public-health perspectives that may provide
insight for potential solutions.

RESULTS AND DISCUSSION
Survey Results
A total of 43 neurosurgeons−29 (67%) from Indonesia and
14 (33%) from the Philippines—had valid responses to the
survey. Majority of respondents (31.8%) cited malignant
intracranial tumors as the neurosurgical condition that causes
the worst economic hardship among patients and their families,
followed by traumatic brain injury (27.3%), spinal trauma
and spinal cord injury (15.9%), and aneurysmal subarachnoid
hemorrhage (15.9%).
In terms of out-of-pocket (OOP) expenses for these
conditions, malignant intracranial tumors were reported to
impose the highest OOP expenses (43.2%), followed by
emergency vascular diseases (38.6%), traumatic brain injury
(34.1%), and degenerative spine disorders (34.1%) (Figure 1).
Among the neurosurgical conditions needing greater financial
subsidy, traumatic brain injury (27.3%) needed the most,
followed by malignant intracranial tumors (18.2%), aneurysmal
subarachnoid hemorrhage (15.9%), and spinal trauma and spinal
cord injury (13.6%) (Figure 2).

MATERIALS AND METHODS
Cross-Sectional Survey
The primary aim of the survey was to determine the
most commonly encountered neurosurgical conditions that
result in financial catastrophe. A secure online survey tool
(Google Forms R ) was used to disseminate the questionnaire
to neurosurgeons currently practicing at public hospitals
in Indonesia and the Philippines. Respondents comprised
a purposive sample of neurosurgeons invited through the
electronic mailing lists of neurosurgical training programs, email
to personal contacts, and social media platforms (WhatsApp and
Viber). The survey was open between 16th February 2021 and
16th March 2021. Those eligible to complete the survey were
neurosurgeons—either as residents or as consultants—whose
practice involves a publicly-funded neurosurgical center as parttime or full-time healthcare provider. Duplicates were removed
via matching those of an identical name and hospital. Because
no patient information was requested from the survey, approval
by an institutional review board was not needed. It is of note
that while the vantage point of patients would be most ideal to
take, the survey has the limitation of inquiring only from the
perspective of neurosurgeons as health service providers because
of its cursory nature in bringing the more important discussion
on solutions to the fore.

Socioeconomic Context of Neurosurgical
Care
Few studies have examined the association between patient-level
socioeconomic factors and outcomes across various diseases
that are treated by the specialty of neurosurgery—pediatric
hydrocephalus (6–8), craniosynostosis (9), intracranial tumors
(10–13), aneurysmal subarachnoid hemorrhage (14, 15)
and stroke (16, 17), traumatic brain injury (18–21), spine
disorders (22) and spinal cord injury (23, 24). Many of
these studies describe the more frequently unfavorable
outcomes among the inadequately insured and those
with lower socioeconomic status. Due to the inherently
costly nature of neurosurgical interventions, many of the
socioeconomically disadvantaged patients seek the necessary
care from public hospitals (4, 5). Whereas such public
neurosurgical centers in Indonesia and the Philippines
are mandated by legislation and government regulation to
provide healthcare at minimum or zero cost, the reality
is that many patients still incur out-of-pocket expenses
(25, 26). These expenses are often catastrophic and push
their families into impoverishment. Financial catastrophe
from accessing surgery remains high in LMICs, and most
of those exposed to such financial risk live in sub-Saharan
Africa and Southeast Asia (1). On the basis of the dearth of
literature on global surgery research related to health financing
(27), we explore the contextual solutions for the costly care
of socioeconomically disadvantaged patients suffering from

Application of Public Health Perspectives
Using principles and perspectives from public health, contractual
management, and financial management, we proffer potential
solutions that can address the gaps in health financing of
neurosurgical services in Indonesia and the Philippines. When
viewed in a public-health context, the problem of catastrophic
and impoverishing expenditures becomes more manageable.

Frontiers in Surgery | www.frontiersin.org
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Health Financing: An Important Health
Systems Function

malignant intracranial tumors and traumatic brain injury in
Indonesia and the Philippines.

Broadly, health financing comprises the mechanisms by which
money is mobilized to fund and pay for health-sector activities,
and how it is used, raised, and paid out to achieve healthrelated outputs (32). Financing and payment arrangements
determine how much money is available or paid out, who
bears the financial burden, who controls the funds, whether
healthcare costs are controlled, and which groups or healthsystem actors are given the incentive (33). A chief method of
health financing is by way of health insurance. The organization
and pooling of both funds and risks are foremost functions
of a health insurance scheme. Many countries, including both
Indonesia and the Philippines, have some form of social health
insurance that is overseen or managed by the government.
Health financing, in a pragmatic sense, is also a matter of policy.
These policies and regulations create powerful incentives that
influence the actions of individuals and organizations in a given
healthcare system.
Socioeconomically disadvantaged patients who seek
healthcare services are often price-sensitive because their
limited means do not allow them to have the capacity to
economically withstand adverse life events such as having a
neurosurgical illness requiring hospitalization. In countries
that do not have a fully responsive health financing or
social protection mechanism—which is more often the case
in LMICs—poor households with a sick member would
finance their health-related costs by way of out-of-pocket
expenses (1, 2). The out-of-pocket expenses they bear can
become “catastrophic,” i.e., household spending equal or
above 40% of non-subsistence income (1, 2). Incurring
health-related catastrophic expenditures pushes patients’
families into impoverishment and affects the volume and
timeliness of healthcare used, in turn influencing overall
health outcomes (32). As far as healthcare utilization is
concerned, the extent of social health insurance coverage
in public hospitals is therefore important. Universal health
coverage and a high degree of responsiveness in curbing outof-pocket expenses on the part of the social health insurance
can improve the accessibility of surgical services, including
that of neurosurgery.

Supply and Demand Sides of
Neurosurgical Care
There are various reasons for the still prevalent high out-ofpocket expenses in LMICs, particularly in Indonesia and the
Philippines. From the demand side of the healthcare system,
both medical and non-medical costs account for the financial
catastrophe suffered by poor patients following surgery (2).
Surgical conditions result in a greater household poverty effect
relative to other health problems and diseases (1, 2, 28).
Poverty plays a role in the unaffordability of transportation
costs and caregiving expenses, while prolonged hospitalization
results in income regression, unemployment, and opportunity
costs for both the patient and the caregiver. The sociocultural
disadvantage of lower levels of education among the poorer
patients contributes to the more advanced presentation of
disease at the time of first consultation. Inadequate health
insurance also contributes to hesitancy in timely health-seeking
behavior—a problem that poses a disadvantage in outcomes
after treatment and prognosis. Furthermore, it does not help
that any neurosurgical intervention, or any surgical treatment
for that matter, is perceived to be costly and expensive
(1). Globally, LMICs have the highest rates of catastrophic
expenditures following receipt of surgical care; and within any
country, most of the burden falls on the poorer segments of
the population (2).
From the supply side of the health system—the healthcare
providers—publicly-funded hospitals generally provide the
needed wide range of emergency and elective neurosurgical care
for poor patients. These hospitals are primarily financed from
taxation and are appropriated a yearly budget from the national
government through the Department or Ministry of Health,
or from local or state-run universities. Many public hospitals
do not have the bare minimum neurosurgical implements,
surgical intensive care units, and even a computed tomography
scanner. These complicate the usual treatment pathway for a
neurosurgical patient—turning it into a cumbersome navigation
around a generally disjointed referral network of hospitals (4,
5, 29). Despite the finite resources that beset governmentfinanced hospitals, neurosurgical care provision in most
centers has been largely sustained by the presence of an
academic neurosurgical training program. The few hospitals
with neurosurgical residency programs in Indonesia and the
Philippines are generally better equipped to handle the more
complicated and full range of neurosurgical diseases and
conditions (30). And yet, like many of the public hospitals
in low-resource settings, the efficiency of care is hampered
by bureaucratic processes and protocols (1). Commonplace
problems like the breakdown of equipment can take time to
repair. The purchase of new equipment often gets encumbered
in elaborate procurement processes (31). In these respects, the
financing of equipment purchase and patient management can
have an important impact on the quality and efficiency of
neurosurgical care.

Frontiers in Surgery | www.frontiersin.org

Expanded Functions for Social Health
Insurance
Social health insurance (SHI) at the national level acts as a payer
for health care goods and services in a country. The Badan
Penyelenggara Jaminan Sosial Kesehatan (BPJSK) is the single
SHI agency in Indonesia while its counterpart is the Philippine
Health Insurance Corporation (PHIC) in the Philippines (26, 34).
The BPJSK and the PHIC finance essential primary care and
specialized care of majority of the acute and chronic illnesses
throughout both the private and public hospital networks. In
the face of limited resources in the public health sectors of
Indonesia and the Philippines, SHI agencies have to do “strategic
purchasing” —essentially to be cost-conscious and efficient in
the selection of cases to be paid for from the pooled funds.
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FIGURE 1 | Neurosurgical conditions causing the worst economic hardship among patients.

FIGURE 2 | Neurosurgical conditions necessitating greater financial subsidy.

FIGURE 3 | Framework for policy and implementation of health financing as applied to neurosurgery.

certainly play a role in providing economic incentives—in the
form of conditional cash transfers, for example—for improving
intermediate indicators of treatment success as well as clinically
important outcomes. See Figure 3 above for the framework.

Financial incentives or other mechanisms can motivate surgical
providers to improve quality and efficiency of care, or to respond
to increased patient demand. Similarly, poor patients respond to
cost savings in the treatment of their illnesses. SHI agencies can

Frontiers in Surgery | www.frontiersin.org
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POTENTIAL HEALTH FINANCING
SOLUTIONS

(22, 23, 41). The case for subsidizing the full costs of treatment
for patients with TBI is also justified by its cost-effectiveness
(42). Strategic purchasing can realize this through contractual
arrangements that would link attractive payment mechanisms to
the goal of broadened access to emergency neurosurgical care
for TBI patients who are brought to the nearest emergency care
facility without regard to the patient’s ability to pay or the type
of facility, whether public or private. Given the context of a low
neurosurgical workforce in both Indonesia and the Philippines,
a task sharing scheme with colleagues from the fields of trauma
and general surgery can also be contractually set in place with the
goal of increasing access to timely neurosurgical trauma referral
(43). A catastrophic illness benefit package may be formulated
by both the BPJSK and the PHIC that would elevate the
financial incentive for all neurosurgical care providers to accept
and manage TBI patients regardless of socioeconomic status
(44, 45). Greater acceptability and buy-in of this mechanism
by neurosurgical providers are afforded by strategic purchasing
because the costing and payment schedules are negotiated and
prearranged in collaboration with the providers themselves. The
payments from SHIs to neurosurgical providers can be further
complemented by an element of pay-for-performance (32), with
a proportion of the fixed payment withheld and paid according
to certain indicators such as timeliness of the surgical operation
(46), long-term outcomes assessment (47), and even patient
satisfaction with the neurosurgeon-patient engagement (48). In
this way, the goal of quality care can be achieved for the
neurosurgical management of patients with TBI.
A prospective payment scheme brought about by strategic
purchasing can enable the pooling of paid out funds on the
part of provider hospitals to accrue future savings (36). The
increased generation of revenue at the level of the hospitals can
result in upfront investments that will finance the capital outlay
costs for scaling up infrastructure and equipment needs, e.g.,
expansion of neurosurgical bed capacity, addition of dedicated
neurosurgical operating theaters, or procurement of costly
neurosurgical equipment. In this manner, the improved capacity
of the provider hospital can increase neurosurgical volume and
the goal of increased access to neurosurgical care can be achieved.
In Table 1 below, we summarize other examples of strategic
purchaser-provider arrangements.

Supply-Side Financing: Strategic
Purchasing of Neurosurgical Services
Ideally, the role of the SHI is to ensure that adequate resources are
mobilized to meet the service entitlements of insured patients—
ideally the whole population—and thus achieve “universal health
coverage.” While financial risk pooling is important for equity
considerations and financial risk protection of the insured, an
added function of strategic purchasing by the SHI can drive the
quality and efficiency of healthcare provision (1, 32, 35). Certain
strategic purchasing methods can modify healthcare providers’
behaviors in their treatment decisions and ultimately influence
the quantity, quality, and efficiency of neurosurgical care for
example. The choice of which disease condition to subsidize is
a matter of policy and executive decision, but is mostly founded
on data on the costs of treatment, the burden of the disease, and
the cost-effectiveness of interventions (36). Assuming the role of
strategic purchaser, the SHI selectively enters into a contract with
neurosurgical care providers. Providers in this sense would mean
the hospital or institution including the neurosurgeons and allied
health professionals. The purchaser and the provider then agree
on a provider payment method for a standard treatment regimen.
Consider for example—traumatic brain injury (TBI)—for
which the current standard of neurosurgical management is
entrenched in universally accepted clinical practice guidelines
(37). Prehospital management of a brain-injured patient is
time-critical. In an analysis of the largest TBI database—
the International Mission for Prognosis And Clinical Trial
(IMPACT) database—Mushkudiani and colleagues concluded
that outcome following TBI is also dependent on race and
to a lesser extent on the level of education of the patient,
even when adjusting for other causes (18). The underlying
reason can be traced to limited access to acute and post-acute
care (20, 21); therefore, prehospital and acute hospital care
systems ought to be efficiently responsive to socioeconomically
disadvantaged patients with TBI (38). Indonesia and the
Philippines have the twin problem of a low neurosurgeon-topopulation ratio −1 per 731,000 and 1 per 807,000, respectively
(30)—and a high prevalence of TBI estimated at around 930 per
100,000 population in the Southeast Asia/Western Pacific region
(39). This situation is exacerbated by constraining financial
considerations whereby a poor TBI patient often gets rushed
to the emergency department of a much farther public hospital
despite the proximity of a private hospital with neurosurgical
services at the time of injury. This adverse selection by
private hospitals presents an added disadvantage for an already
economically disadvantaged patient with TBI, whose clinical
outcome could have been better were it not for a delayed
neurosurgical treatment.
Conceptually, strategic purchasing allows buying of health
services for certain groups of patients and uses financial levers
and payment schemes that influence the behavior of providers
including hospitals and neurosurgeons (35, 36, 40). The results of
our survey in this study indicate that TBI is viewed as requiring
greater financial subsidies, as similarly found in other studies

Frontiers in Surgery | www.frontiersin.org

Demand-Side Financing: Conditional Cash
Transfers for Neurosurgical Patients
Neurosurgical patients, herein considered the demand side of
healthcare provision, constitute an important stakeholder in
terms of health financing. Despite the fact that surgery in
public hospitals is completely subsidized by the BPJSK in
Indonesia and the PHIC in the Philippines—at little to zero
cost for indigent patients—there remain substantial financial
barriers (36). Frequently, financial catastrophe comes from nonmedical costs of care, such as the cost of transportation and
living expenses of the caregiver (1, 2). For socioeconomically
disadvantaged patients in the Philippines, even in-person
outpatient follow-up after neurosurgery entails catastrophic
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TABLE 1 | Purchaser-provider contractual management for health financing.
Strategic purchasing functions*

Examples for neurosurgery

1 Providing an appropriate range of services and locations
relative to the distribution of the population by means of
effective gatekeeping and referral

• Assignment of tiered neurosurgical centers (e.g., higher level and lower level) with a predefined
catchment population based on geography and complexity of disease condition
• Creation of centers of excellence for certain neurosurgical disease conditions based on
available expertise of subspecialist neurosurgeons

2 Selecting providers for accreditation

• Designating and credentialing private hospitals that are capable of accepting and managing
traumatic brain injury and emergency neurovascular diseases
• Selective contracting and progressive policy of deliberated reimbursement of expenses by
accredited private hospitals that are incurred during emergency operations for indigent
patients with traumatic brain injury and stroke

3 Implementing provider payment methods efficiently, as in a
prospective payment system

• Creation of a catastrophic illness benefit package for traumatic brain injury and/or malignant
intracranial tumors
• Capitation funding for every indigent patient who gets admitted in a private hospital on an
emergency basis and who needs life-saving neurosurgical intervention

4 Making use of monopsonistic purchasing power

• Public-private partnership and debt financing for the capital outlay of infrastructure projects
• Economies of scale purchasing arrangements for neurosurgical consumable implements

5 Introducing generic essential drugs, devices, or implants lists

• Creation of a medicines access program for disease-altering drugs, e.g., temozolamide for
patients with gliomas
• Consignment and purchasing arrangements for steady supply of cranial and spinal implants
and instrumentation

6 Monitoring provider performance in terms of quality
and efficiency

• Establishing a prospective database of outcomes report following surgery and adjuvant
chemoradiotherapy for patients with gliomas
• Merit-based payment and reimbursement of neurosurgical centers based on
volume-outcome relationships, e.g., high-volume centers doing >10 intracranial aneurysms
per year will have seamless financing for purchase of aneurysm clips

7 Ensuring mutual accountability between purchasers and
providers through timely payments to healthcare providers and
appropriate audit systems

• Checks and balances system that would minimize fraud and pilferage of payments and
reimbursements, e.g., repeated neuroimaging of neurosurgical patients will have to be easily
cross-checked through linkage with information technology systems
• Strict penalty system for breach in contracts when it comes to timeliness of reimbursements,
especially for time-critical and life-threatening neurosurgical operations

*Adapted from: Trisnantoro L, Hendrartini J, Susilowati T, Miranti PAD, Aristianti V. Chapter 3: A critical analysis of selected healthcare purchasing mechanisms in Indonesia. In: Honda
A, McIntyre D, Hanson K, Tangcharoensathien V. ed. by. Strategic Purchasing in China, Indonesia, and the Philippines (Comparative Country Studies, Vol. 2 No. 1 2016). Geneva: World
Health Organization; 2016. p. 124.

expenses and may cause adverse life events that can negatively
impact health-seeking behavior overall (49).
The results of our survey show that out-of-pocket expenses
surrounding the management of those with malignant
intracranial tumors are a prevalent form of health financing in
Indonesia and the Philippines. For majority of patients with
brain cancer in Indonesia and the Philippines, the standard
Stupp protocol for the treatment of glioblastoma could bankrupt
their families—often resulting in the patient never receiving
or completing the disease-altering adjuvant chemotherapy and
radiotherapy. Adjuvant chemotherapy for glioblastoma is carried
out on an outpatient basis: consultations are done at the oncology
clinic during the course of the patient’s ongoing intake of oral
drugs (temozolamide). However, SHIs are currently not fully
responsive in the aspect of financing for adjuvant therapy and
outpatient care. The responsibility of payment for the adjuvant
treatments is frequently left to the social welfare division of
the hospital or external charitable organizations (45). In the
Philippines, the PHIC pays for a so-called “Z Benefit” package
for the full treatment course of certain catastrophic illnesses
including early breast, colon, and rectum cancers, but not brain
cancer. The subsidies offered by the PHIC for colorectal and
breast cancer patients have helped achieve better mortality

Frontiers in Surgery | www.frontiersin.org

rates and overall better compliance to treatment. In Indonesia,
patients with glioblastoma get full subsidies but the BPJSK
no longer routinely pays for the treatment costs of recurrent
glioblastoma. In the two countries, this situation results in dismal
follow-up at baseline and at worst, poor long-term survival
among patients with glioblastoma.
The case for subsidizing the full costs of treatment for patients
with glioblastoma is justified by its cost-effectiveness (50) and the
fact that brain cancer is one of the leading neurological causes of
mortality in the Southeast Asian region that are relevant to the
neurosurgeon (51). While full subsidies for the Stupp protocol
through some form of strategic purchasing appears to be the
preeminent solution, the added strategy of using cash transfers
for patients with glioblastoma can modify the behavior of the
demand-side of neurosurgical care provision. Conditional cash
transfers (CCT)—in which recipients are given some amount
of money, often conditional on their adherence to a desired
behavior—have been used by social welfare programs to reduce
poverty and to incentivize salutary action for a number of publichealth interventions (52, 53). In Indonesia and the Philippines, a
CCT scheme is employed in both countries as a form of social
assistance; but unique to the Philippine context is the use of
CCT to encourage health-related behaviors among household
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the added challenges of incurring out-of-pocket expenses and
risking financial catastrophe whenever they navigate the health
system for treatment. This situation calls for a more robust
and responsive health financing for neurosurgical services. From
an economic perspective, health financing for neurosurgery
entails the proposition for addressing the demand (patient)
or supply (provider) sides of healthcare provision. Strategic
purchasing enables a systematic and contractual management
of payment arrangements that provide performance-based
economic incentives for providers that can in turn help achieve
the goals of quality and efficiency of neurosurgical care provision.
Conditional cash transfers similarly leverages on financial
incentives on the part of patients to reward certain health-seeking
behaviors that significantly influence clinical outcomes. These
health financing strategies are formulated in order to ultimately
build neurosurgical capacity in LMICs, improve access to care for
patients, and ensure financial risk protection. It is hoped that this
article provides a framework for implementation and affords a
basic understanding of health financing that can inform policy
and advocacy work among neurosurgeons globally.

beneficiaries in addition to the requirement of sending the
children to school (54). This health-related requirement however,
is only limited to attendance in family development lectures
on parental, family, and community responsibilities (54). While
there is high-quality evidence that the effects of CCT translate to
better outcomes in terms of family and child health (55), similar
evidence for surgical, or even neurosurgical care for that matter,
currently remains limited. Determining the optimal amount of
cash transfers that would modify the health-seeking behavior
of surgical patients can be difficult but recent findings from a
modeling study suggest a dose-response relationship between the
amount of money given and compliance to scheduled surgery
(56). The study by Strader et al. noted that until after baseline
costs of surgery are paid for by the purchaser—and thus becomes
free for the patient—only then can any incremental increase in
the amount of cash transfer be expected to improve compliance.
CCTs for patients with glioblastoma may be done to decrease
the no-show rate in follow-up consultation schedules and
improve the all too common problem of loss to follow-up.
The direct provision of cash for indigent patients can be made
contingent on their adherence to adjuvant treatment following
neurosurgical operation for glioblastoma. In turn, the families’
non-medical costs are also subsidized. Furthermore, CCTs also
have positive externalities and can be expected to increase the
propensity of the household members to have some degree of
trust in the systems of healthcare provision and health financing.
In this manner, financial barriers to neurosurgical services are
actually lowered and a system is set in place to reward beneficial
health-seeking behavior that impacts patient outcomes.
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